Posluma Approved for PET Imaging in Prostate Cancer
Flotufolastat fluorine-18 (Posluma), a new PSMA-targeted PET radiopharmaceutical, has been approved in the US for use in prostate cancer.
Source: medscape.com
Page 11 - Ancer Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ancer Prostate Today - Breaking & Trending Today
ChatGPT in Medicine: The Good, the Bad, and the Unknown
Three physician experts discuss the enormous potential of ChatGPT and share their concerns about the rapidly evolving technology.
Source: medscape.com
Weight Gain Before 30 Raises Risk for Fatal Prostate Cancer
The researchers looked at data for 258,477 men who had at least three weight measurements between the ages of 17 and 60 years.
Source: medscape.com
TNF, JAK Inhibitors' CV Safety Compared in PsA, AxSpA
JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.
Source: medscape.com
Limit PSA Screening to Men With Symptoms
A new strategy that would limit screening for prostate cancer to men under 70 who are at risk or symptomatic would reduce the potential harm from overdiagnosis and overtreatment, an international panel recommends.
Source: medscape.com